首页> 外文期刊>Organic & biomolecular chemistry >O-Phenylenediamine: a privileged pharmacophore of ferrostatins for radical-trapping reactivity in blocking ferroptosis
【24h】

O-Phenylenediamine: a privileged pharmacophore of ferrostatins for radical-trapping reactivity in blocking ferroptosis

机译:O-Phenylenediamine:铁制他汀类药物的一种特权药效基团,可在阻止铁锈病中产生自由基捕获反应

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Ferroptosis is a non-apoptotic, iron dependent form of regulated cell death that is characterized by the accumulation of lipid hydroperoxides. It has drawn considerable attention owing to its putative involvement in diverse neurodegenerative diseases. Ferrostatins are the first identified inhibitors of ferroptosis and they inhibit ferroptosis by efficiently scavenging free radicals in lipid bilayers. However, their further medicinal application has been limited due to the deficient knowledge of the lipid peroxyl radical-trapping mechanism. In this study, experimental and theoretical methods were performed to illustrate the possible lipid hydroperoxide inhibition mechanism of ferrostatins. The results show that an ortho-amine (-NH) moiety from ferrostatins can simultaneously interact with lipid radicals, and then form a planar seven-membered ring in the transition state, and finally present greater reactivity. NBO analysis shows that the formed planar seven-membered ring forces ortho-amines into better alignment with the aromatic π-system. It significantly increases the magnitudes of amine conjugation and improves spin delocalization in the transition state. Additionally, a classical H-bond type interaction was discovered between a radical and an o-NH group as another transition state stabilizing effect. This type of radical-trapping mechanism is novel and has not been found in diphenylamine or traditional polyphenol antioxidants. It can be said that o-phenylenediamine is a privileged pharmacophore for the design and development of ferroptosis inhibitors.
机译:Ferroptosis是受调节的细胞死亡的一种非凋亡的铁依赖性形式,其特征是脂质氢过氧化物的积累。由于它可能参与多种神经退行性疾病,因此引起了相当大的关注。 Ferrostatins是最早被鉴定为肥大症的抑制剂,它们通过有效清除脂质双层中的自由基来抑制肥大症。然而,由于对脂质过氧自由基捕获机理的了解不足,其进一步的医学应用受到了限制。在这项研究中,进行了实验和理论方法,以说明铁他汀类药物可能抑制脂质过氧化氢的机制。结果表明,来自铁抑素的邻胺(-NH)部分可同时与脂质自由基相互作用,然后在过渡态形成平面的七元环,并最终呈现出更高的反应性。 NBO分析表明,形成的平面七元环迫使邻胺与芳族π系统更好地排列。它显着增加了胺共轭的幅度,并改善了过渡态下的自旋离域。另外,在自由基和o-NH基团之间发现了经典的H键型相互作用,作为另一种过渡态稳定作用。这种类型的自由基捕获机制是新颖的,尚未在二苯胺或传统的多酚抗氧化剂中发现。可以说,邻苯二胺是设计和开发类铁质病抑制剂的特权药效团。

著录项

  • 来源
    《Organic & biomolecular chemistry》 |2018年第21期|3952-3960|共9页
  • 作者单位

    College of Chemistry, Chemical Engineering and Materials Science, Collaborative Innovation Center of Functionalized Probes for Chemical Imaging in Universities of Shandong, Key Laboratory of Molecular and Nano Probes, Ministry of Education, Shandong Provincial Key Laboratory of Clean Production of Fine Chemicals, Shandong Normal University, Jinan 250014, P. R. China.;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号